These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15553595)

  • 21. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
    Altstaedt HO; Berzewski B; Breddin HK; Brockhaus W; Bruhn HD; Cachovan M; Diehm C; Dörrler J; Franke CS; Gruss JD
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
    Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
    Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sympathectomy and intra-arterial perfusion therapy in critical ischemia of the lower limbs].
    Karimov ZZ; Bakhritdinov FSh; Soatov RR; Likhacheva TA
    Vestn Khir Im I I Grek; 1999; 158(5):19-21. PubMed ID: 10645573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
    Ranke C; Creutzig A; Alexander K
    Med Klin (Munich); 1991 Jul; 86(7):349-52, 382. PubMed ID: 1921896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of sympathectomy on the microcirculation in obliterating diseases of the arteries of the extremities].
    Reut AA; Vostrikov IaSh
    Khirurgiia (Mosk); 1977 May; (5):12-7. PubMed ID: 864956
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indications and limitations of sympathectomy].
    Fontaine JL; Leonard P
    Rev Clin Esp; 1979 Sep; 154(6):251-6. PubMed ID: 531299
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T; Eckstein H; Weiss C; Diehm C
    Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lumbar sympathectomy as isolated technique for the treatment of lower limbs chronic ischemia.
    Perez-Burkhardt JL; Gonzalez-Fajardo JA; Martin JF; Carpintero Mediavilla LA; Mateo Gutierrez AM
    J Cardiovasc Surg (Torino); 1999 Feb; 40(1):7-13. PubMed ID: 10221378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemical lumbar sympathectomy in patients with chronic ischemia of the lower extremities].
    Piatko VE; Sukhotin SK
    Anesteziol Reanimatol; 2004; (4):31-3. PubMed ID: 15468551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of arterial circulation disorders. Clinical results after lumbar sympathectomy].
    Sunkat R; Zimmermann U; Seboldt H; Hoffmeister HE
    Fortschr Med; 1974 Jun; 92(16):694-6. PubMed ID: 4836000
    [No Abstract]   [Full Text] [Related]  

  • 35. [Distal arteritis of the legs: lumbar sympathectomy].
    Vayssairat M; Gouny P; Baudot N; Gaitz JP; Nussaume O
    J Mal Vasc; 1994; 19 Suppl A():174-7. PubMed ID: 8158080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
    Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
    Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood flow measurements in arterial surgery of lower limb.
    Rocher A; Basyn ML; Joos FE
    J Cardiovasc Surg (Torino); 1975; 16(4):384-5. PubMed ID: 1184668
    [No Abstract]   [Full Text] [Related]  

  • 39. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
    Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
    [No Abstract]   [Full Text] [Related]  

  • 40. [Indications for performing lumbar sympathectomy].
    Lur'e FE
    Klin Khir (1962); 1991; (7):52-5. PubMed ID: 1942836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.